Table 2.
BMD changes after treatment.
| Patient number | Lumbar BMD (g/cm2) |
Femoral neck BMD (g/cm2) |
||||
|---|---|---|---|---|---|---|
| Before administering romosozumab | 6 months later | 1 year later | Before administering romosozumab | 6 months later | 1 year later | |
| 1 | 0.478 | 0.628 | 0.668 | 0.339 | 0.331 | 0.421 |
| 2 | 0.438 | 0.520 | 0.524 | 0.417 | 0.547 | 0.513 |
| 3 | 0.491 | 0.575 | 0.620 | 0.314 | 0.327 | 0.366 |
| 4 | 0.653 | 0.714 | 0.756 | 0.456 | 0.420 | 0.409 |
| 5 | 0.906 | 0.959 | 0.999 | 0.490 | 0.475 | 0.547 |
| Mean ± SD | 0.593 ± 0.193 | 0.679 ± 0.172 | 0.713 ± 0.180 | 0.403 ± 0.075 | 0.420 ± 0.095 | 0.451 ± 0.075 |
| P-value | 0.01* | 0.00* | 0.60 | 0.13 | ||
*P-value <0.05; statistically significant compared to before administering romosozumab.
SD, standard deviation; BMD, bone mineral density.